The combination is indicated for the treatment of human immunodeficiency virus 1 (HIV 1) infection in people weighing at least 14 kilograms (31 lb) without present or past evidence of viral resistance to the integrase inhibitor class, emtricitabine or tenofovir.

Bictegravir/emtricitabine/tenofovir alafenamide has been investigated for post-exposure prophylaxis (PEP) for preventing HIV infection after exposure and has shown positive early results.

The post Bicstar (generic biktarvy) 30 tablets first appeared on Online pharmacy | Generic medications | Fair prices | Rx drugs.

For HIV 1 infection, tenofovir is indicated in combination with other antiretroviral agents for people 2 years of age and older. For chronic hepatitis B patients, tenofovir is indicated for patients 12 years of age and older.

It may be used for prevention of HIV and AIDS among those at high risk before exposure, and after a needlestick injury or other potential exposure.

Tenofovir can be used for HIV prevention in people who are at high risk for infection through sexual transmission or injecting drug use. A Cochrane review examined the use of tenofovir for prevention of HIV before exposure and found that both tenofovir alone and the tenofovir and emtricitabine combination decreased the risk of contracting HIV for high risk patients.

The post Tenvir EM (generic emtricitabine and tenofovir disoproxil) 30 tablets first appeared on Online pharmacy | Generic medications | Fair prices | Rx drugs.